PRODUCTS
FlexISH ® BCL2/BCL6 DistinguISHTM Probe
The FlexISH ® BCL2/BCL6 DistinguISHTM Probe is designed to detect rearrangements involving the chromosomal regions 18q21.33 and 3q27.3 harboring the BCL2 (B-Cell CLL/Lymphoma 2, a.k.a. PPP1R50) gene and the BCL6 (B-Cell CLL/ Lymphoma 6, a.k.a. ZNF51, LAZ3) gene, respectively. Using this probe, it is possible to simultaneously detect BCL2 and/or BCL6 rearrangements commonly found in double-hit lymphoma (DHL) or triple-hit lymphoma (THL).
Probe Maps
Ordering Information
| Prod. No.: | Tests¹ (Volume): | Intended Use²: | ||
|---|---|---|---|---|
| Z-2283-50 |
|
 |
||
| Z-2283-200 |
|
|
Download Information
| 1 | Using 10 μl probe solution per test. |
| 2 | In vitro diagnostic medical device according to EU directive 98/79/EC. CE IVD only available in certain countries. All other countries research use only! Please contact your local dealer for more information. |
